
Bridget E. Bunner
Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1463 |
| Issued Applications | 725 |
| Pending Applications | 157 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8689978
[patent_doc_number] => 08389505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 13/107492
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6319
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107492 | Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor | May 12, 2011 | Issued |
Array
(
[id] => 8104077
[patent_doc_number] => 08153683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Methods of treatment using a prodrug of an excitatory amino acid'
[patent_app_type] => utility
[patent_app_number] => 13/100642
[patent_app_country] => US
[patent_app_date] => 2011-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48982
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153683.pdf
[firstpage_image] =>[orig_patent_app_number] => 13100642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/100642 | Methods of treatment using a prodrug of an excitatory amino acid | May 3, 2011 | Issued |
Array
(
[id] => 9086351
[patent_doc_number] => 08557780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Monomethylvaline compounds capable of conjugation to ligands'
[patent_app_type] => utility
[patent_app_number] => 13/098393
[patent_app_country] => US
[patent_app_date] => 2011-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 43
[patent_no_of_words] => 80714
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/098393 | Monomethylvaline compounds capable of conjugation to ligands | Apr 28, 2011 | Issued |
Array
(
[id] => 9009441
[patent_doc_number] => 08524739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Quinoline derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/093261
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17810
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13093261
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093261 | Quinoline derivatives and uses thereof | Apr 24, 2011 | Issued |
Array
(
[id] => 9503571
[patent_doc_number] => 08741884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Compounds for the treatment of hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 13/086704
[patent_app_country] => US
[patent_app_date] => 2011-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31228
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086704
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/086704 | Compounds for the treatment of hepatitis C | Apr 13, 2011 | Issued |
Array
(
[id] => 6168380
[patent_doc_number] => 20110196147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'INHIBITORS OF HISTONE DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 13/079458
[patent_app_country] => US
[patent_app_date] => 2011-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107590
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196147.pdf
[firstpage_image] =>[orig_patent_app_number] => 13079458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/079458 | INHIBITORS OF HISTONE DEACETYLASE | Apr 3, 2011 | Abandoned |
Array
(
[id] => 10613842
[patent_doc_number] => 09333269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Polyplex gene delivery vectors'
[patent_app_type] => utility
[patent_app_number] => 13/635640
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 7815
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635640 | Polyplex gene delivery vectors | Mar 20, 2011 | Issued |
Array
(
[id] => 8049223
[patent_doc_number] => 20120074336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'LIGHT-DRIVEN ROTARY MOLECULAR MOTORS'
[patent_app_type] => utility
[patent_app_number] => 13/051439
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21131
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20120074336.pdf
[firstpage_image] =>[orig_patent_app_number] => 13051439
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/051439 | LIGHT-DRIVEN ROTARY MOLECULAR MOTORS | Mar 17, 2011 | Abandoned |
Array
(
[id] => 10026067
[patent_doc_number] => 09067953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Systems for carbon dioxide and sulfur dioxide removal'
[patent_app_type] => utility
[patent_app_number] => 13/045578
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6175
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045578
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045578 | Systems for carbon dioxide and sulfur dioxide removal | Mar 10, 2011 | Issued |
Array
(
[id] => 6016853
[patent_doc_number] => 20110224229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'Novel Crystalline Form'
[patent_app_type] => utility
[patent_app_number] => 13/043697
[patent_app_country] => US
[patent_app_date] => 2011-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224229.pdf
[firstpage_image] =>[orig_patent_app_number] => 13043697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043697 | Novel Crystalline Form | Mar 8, 2011 | Abandoned |
Array
(
[id] => 9026580
[patent_doc_number] => 08536162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates'
[patent_app_type] => utility
[patent_app_number] => 13/044220
[patent_app_country] => US
[patent_app_date] => 2011-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3729
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13044220
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/044220 | Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates | Mar 8, 2011 | Issued |
Array
(
[id] => 7501693
[patent_doc_number] => 20110263581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'FUSED TRICYCLIC COMPOUNDS AS SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/035640
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 43241
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263581.pdf
[firstpage_image] =>[orig_patent_app_number] => 13035640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/035640 | Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators | Feb 24, 2011 | Issued |
Array
(
[id] => 6064958
[patent_doc_number] => 20110201806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Methods for Forming Protected Organoboronic Acids'
[patent_app_type] => utility
[patent_app_number] => 13/030833
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17930
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201806.pdf
[firstpage_image] =>[orig_patent_app_number] => 13030833
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/030833 | Methods for forming protected organoboronic acids | Feb 17, 2011 | Issued |
Array
(
[id] => 6083941
[patent_doc_number] => 20110144094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'HETEROCYCLIC TETRACYCLIC TETRAHYDROFURAN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/028596
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11315
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144094.pdf
[firstpage_image] =>[orig_patent_app_number] => 13028596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/028596 | Heterocyclic tetracyclic tetrahydrofuran derivatives | Feb 15, 2011 | Issued |
Array
(
[id] => 9691865
[patent_doc_number] => 08822459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Compound containing basic group and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/027957
[patent_app_country] => US
[patent_app_date] => 2011-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70368
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13027957
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/027957 | Compound containing basic group and use thereof | Feb 14, 2011 | Issued |
Array
(
[id] => 7778937
[patent_doc_number] => 20120041190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'MACROCYCLES AS FACTOR XIA INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/024544
[patent_app_country] => US
[patent_app_date] => 2011-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 139964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041190.pdf
[firstpage_image] =>[orig_patent_app_number] => 13024544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/024544 | Macrocycles as factor XIa inhibitors | Feb 9, 2011 | Issued |
Array
(
[id] => 10082523
[patent_doc_number] => 09119853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Sanglifehrin based compounds'
[patent_app_type] => utility
[patent_app_number] => 13/575212
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26513
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575212 | Sanglifehrin based compounds | Feb 8, 2011 | Issued |
Array
(
[id] => 9009595
[patent_doc_number] => 08524893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Process for the preparation of temsirolimus and its intermediates'
[patent_app_type] => utility
[patent_app_number] => 13/016235
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3467
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13016235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/016235 | Process for the preparation of temsirolimus and its intermediates | Jan 27, 2011 | Issued |
Array
(
[id] => 8638556
[patent_doc_number] => 20130030359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'DIPEPTIDE-BASED PRODRUG LINKERS FOR AROMATIC AMINE-CONTAINING DRUGS'
[patent_app_type] => utility
[patent_app_number] => 13/574157
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19243
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574157
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/574157 | DIPEPTIDE-BASED PRODRUG LINKERS FOR AROMATIC AMINE-CONTAINING DRUGS | Jan 20, 2011 | Abandoned |
Array
(
[id] => 9216375
[patent_doc_number] => 08629175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Functional food additives'
[patent_app_type] => utility
[patent_app_number] => 13/518929
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3206
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518929
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/518929 | Functional food additives | Dec 22, 2010 | Issued |